| Shella Yu, MSN, FNP-C | |
|
150 S Raymond Ave, Alhambra, CA 91801-3166 | |
| (626) 300-0800 | |
| Not Available |
| Full Name | Shella Yu |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 150 S Raymond Ave, Alhambra, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689184269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 95007518 (California) | Primary |
| Entity Name | Shen Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457427221 PECOS PAC ID: 8527164482 Enrollment ID: O20070509000575 |
News Archive
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.
Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published online October 21 in the Journal of the National Cancer Institute.
Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shella Yu, MSN, FNP-C 1801 S Olive Ave, Alhambra, CA 91803-3163 Ph: (626) 689-6302 | Shella Yu, MSN, FNP-C 150 S Raymond Ave, Alhambra, CA 91801-3166 Ph: (626) 300-0800 |
News Archive
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.
Among known risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol consumption, along with chronic hepatitis B and C infection, contribute to a large share of the disease burden in Europe, according to a cohort study published online October 21 in the Journal of the National Cancer Institute.
Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
› Verified 9 days ago
Vivien Chan Trieu, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1917 Edgewood Dr, Alhambra, CA 91803 Phone: 626-203-8889 | |
Hsing-chun Hsieh, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 116 S Chapel Ave Apt V, Alhambra, CA 91801 Phone: 626-399-3423 | |
Yuan Yao, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 925 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-0282 | |
Jackeline Tekin, NURSE PRACTITIONER Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2835 W Valley Blvd, Alhambra, CA 91803 Phone: 626-281-3265 | |
Mrs. Rosario Maria Aguilar-tanphanich, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1701 La Golondrina Ave, Alhambra, CA 91803 Phone: 626-476-8462 | |
Thuy M Nguyen, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2102 San Clemente Ave, Alhambra, CA 91803 Phone: 323-580-3076 | |
Shuhua Guo, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10 W Bay State St, Alhambra, CA 91802 Phone: 626-265-6371 |